Have you ever wondered how doctors determine the treatment for a blood cancer patient? In this episode, we’re speaking with Dr. Eric Severson of Labcorp Oncology and Dr. John DiPersio of Washington University in St. Louis, MO, about genomics testing, what it is, and how it benefits blood cancer patients. You will learn about the crucial collaboration between pathologists and oncologists to make sure patients are getting the most accurate diagnosis and best possible treatments for their particular blood cancers.
Podcast: Play in new window | Download
Subscribe: Google Podcasts | Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Genomics Testing Video
- Genomics Tests (FISH, Flow Cytometry, Next-generation Sequencing)
- Acute Myeloid Leukemia
- Minimal/Measurable Residual Disease
- A Medication Resource for Blood Cancer Patients
- Minimal/Measurable Residual Disease Chart
- CAR T-cell Therapy
- Stem Cell Transplantation
- Beat AML Master Clinical Trial
- Dare To Dream
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Clinical Trial Support Center
- Financial support
- Young Adult Resources
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Online chats
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by: Labcorp Oncology.
Thank you!
Excellent! Very informative and understandable! Please thank the participating doctors for taking the time to share and paint a more complete picture of how genomics are benefiting precision oncology. It was very helpful to me.
This information has been very informative for our hearing. Dare not to hope.